Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined mouthwash versus chlorhexidine mouthwash in acute pericoronitis
IRCT20230104057046N1Phase 3Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- Feb 2023
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, open-label trial of chlorhexidine, benzydamine, silver nanoparticles, amoxicillin and metronidazole in pericoronitis (2 arms), sponsored by Golestan University of Medical Sciences. Primary endpoints: pain and maximum mouth opening. Started Feb 2023; status: completed.
02
Drugs
chlorhexidinebenzydaminesilver nanoparticlesamoxicillinmetronidazole
03
Conditions
pericoronitis
Beyond the preview
Go deeper on IRCT20230104057046N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230104057046N1.